Top Biopharmaceutical Experts 2025

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Biosync Pharmaceuticals is a reputed PCD Pharma Franchise company in India, offering a comprehensive range of DCGI and GMP-certified products across therapeutic categories. With region-wise monopoly rights, prompt delivery, and robust promotional support, Biosync empowers pharma entrepreneurs to build flourishing businesses backed by quality and trust. Join the network that values transparency and long-term growth.

Aldo Vidinha is an internationally experienced leader with more than 18 years of expertise in the pharmaceutical industry, specializing in Engineering, Validation & Qualification, GMP Compliance, Quality Assurance, and Manufacturing. Throughout his career, he has successfully led and delivered the construction, start-up, commissioning, qualification, and validation of multiple pharmaceutical manufacturing facilities across Europe, the USA, Australia, and China. As a Project Lead, Aldo has managed capital expenditure projects valued at up to €18 million for major international pharmaceutical players. His proven track record demonstrates his ability to navigate complex technical and regulatory challenges while delivering projects on time and to the highest quality standards. Beyond his technical expertise, Aldo is a highly driven and motivated leader known for his strategic thinking and ability to build high-performance teams. He brings a unique combination of deep industry knowledge and strong business acumen, enabling him to contribute at both executive and governance levels. His areas of professional interest include engineering innovation, sustainability, Industry 4.0 and 5.0, and the advancement of pharmaceutical validation and qualification practices. With a passion for shaping the future of pharmaceutical engineering, Aldo continues to make a significant impact on the industry through leadership, thought partnership, and consulting.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Co-Founder of CellX, an evidence-based supplement company in Mexico. Author of The Everyday Blueprint (forthcoming), a longevity protocol based on 400+ scientific studies. Background in digital strategy (Kellogg, Queen Mary MBA). Expertise: supplement quality standards, longevity science, functional nutrition, the Mexican health market, evidence-based supplementation, and building health brands in emerging markets.

I entered the hemp space at the very beginning when there were almost no guardrails, no industry playbook, and very few operators who truly understood what it took to formulate something that actually worked. Hemp-derived flower and hemp wellness products were barely a category. What existed was largely untested, poorly sourced, and built around novelty rather than need. From day one, our approach was different purpose before profit, formulation before marketing, and a deep belief that every formulation should serve a real purpose. At JustKana, I oversee product development, quality control, and sourcing from the ground up. That means building relationships directly with small-batch organic hemp farms, evaluating raw material quality before it ever reaches a formulation stage, and ensuring every finished product meets both our internal standards and third-party lab verification. My work lives at the intersection of plant science and consumer wellness. I specialize in cannabinoid formulation for real therapeutic outcomes sleep support, chronic pain relief, anxiety management, and inflammation using full-spectrum hemp extracts that preserve the natural compound profile of the plant rather than isolating single ingredients. Over the years I've helped develop products that have made a measurable difference for thousands of people veterans managing PTSD, seniors dealing with chronic joint pain, and individuals looking to replace pharmaceutical sleep aids with something cleaner and plant-derived. That direct connection to consumer outcomes shapes every formulation decision I make. I understand the hemp supply chain from soil to finished product cultivation practices, extraction methods, cannabinoid and terpene profiles, and how sourcing decisions downstream directly impact what a customer experiences. In a space flooded with white-labeled, mass-produced products, that depth of knowledge is rare.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Skilled, highly knowledgeable, and analytical professional with over fourteen years experience in the healthcare sector. Primary expertise in providing strategic insights and actionable information to life science companies. Proficient in molecular diagnostics, point of care diagnostics, genomics, immunoassays, oncology diagnostics, cardiology diagnostics, infectious disease diagnostics and personalized medicine. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations. Specialties: Extensive knowledge in the genomics, in-vitro diagnostics space. Demonstrated success in managing teams and clients, assessing business models identifying market opportunities/risks and developing strategies to optimize market penetration, competitive advantage and profit.

Plant-based raw food expert with 16+ years of personal practice backed by 21+ years of medical records. Seven-time marathoner. Founder of Raw Foodiest coaching platform. Publishing IN NATURE WE TRUST manifesto March 2026. I teach energy-based health principles grounded in real-world results, not recipes.

I am a third-generation pharmacist with certifications in pharmacogenetics and antepartum doula care, specializing in maternal health and medication safety. After earning my PharmD from Creighton University and a BS in Hospitality from UNLV, I built a career spanning hospital and retail pharmacy, consulting, entrepreneurship, telemedicine, and medical affairs. Currently, I work as a medical science liaison while continuing to consult and practice as a hospital pharmacist. My expertise is grounded in both research and lived experience. After enduring three pregnancies complicated by Hyperemesis Gravidarum (HG), I founded HG Pharmacist® and Obstet-Rx to provide personalized medication guidance, integrate pharmacogenetics into maternal care, and advocate for women worldwide. My research includes genetic predictors of ondansetron effectiveness and recurrence risk for HG, and I have published extensively on maternal health. I also served on the HER Foundation board from 2019 to 2021 and frequently present at professional conferences. As host of the MaternalRx podcast on the Pharmacy Podcast Network, I highlight the pharmacist’s role in maternal outcomes, drawing from my background in specialty diagnostics such as preeclampsia biomarkers, iron deficiency anemia, and oncology supportive therapies. This blend of patient advocacy, clinical expertise, and medical affairs experience positions me as a trusted voice on maternal health, medication management, and the evolving role of pharmacists in healthcare. When I’m not speaking or consulting, I enjoy yoga, ice skating, and time outdoors with my dog. I welcome opportunities to collaborate with media to shed light on maternal health challenges, the importance of personalized medicine, and strategies to improve patient outcomes.

My expertise is in entrepreneurship, nutrition, fitness, and creating innovative food products. With a rags to riches story, I’ve hosted podcasts and had conversations with world class performers, professionals, writers, and researchers. I’m the creator of Energy Pods, the most innovative and versatile meal replacement food product, and CocoZen, a 12 oz sugar-free and nutritious spread, both of which are made in Napa, California.

I build composites in carbon fiber and carbon aramid kevlar primarily for automotive. I focus on nostalgic and enthusiast vehicles. I'm currently building a full wide body carbon fiber 90s BMW right now. I used to work for the non-profit world, I have worked for the corporate world; neither is for me. now. I work for myself and I work for my dreams. It's the hardest I've ever worked but it's also the most creative I've ever been. I've never been so rewarded financially self-investing in my dreams. IG Grimoire Aerowerks

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Ganesh Ariyur is a global enterprise technology executive and a Top 100 Digital Adoption Leader for 2025. He is known for delivering more than $500M in measurable enterprise value through large-scale digital transformation, enterprise systems modernization, cloud strategy, artificial intelligence adoption, data governance, & enterprise architecture leadership. His work spans more than 90 countries across Fortune 500 organizations, private-equity owned companies, and highly regulated industries. Ganesh serves as the Global Head of Enterprise Technology Strategy and Transformation at Gainwell Technologies, a $3B healthcare technology organization. He directs modernization programs across SAP S/4HANA, Oracle Cloud ERP, PeopleSoft, cloud platforms on AWS and Azure, enterprise applications, reporting and analytics, generative AI, intelligent automation, enterprise architecture, IT governance, and cybersecurity, aligned with operating models. His programs have delivered multi-million-dollar cost savings. He has directed enterprise portfolios valued at more than $1B. He has unified 450-plus legacy systems, led technology programs supporting more than $30B in M&A value, and guided organizations through complex TSA exits and carve-outs. Ganesh brings deep expertise in artificial intelligence-enabled operating models, multi-ERP modernization including SAP S/4 HANA, Oracle Cloud, & Workday, cloud strategy and FinOps, enterprise architecture, data, infrastructure, cybersecurity improvement, data quality & analytics modernization, robotic process automation & intelligent automation, shared services/global business services, organizational design, and long-term value creation. His people-process-technology approach led to his being named a Global Top 100 Digital Adoption Leader. He is a Certified AI Business Transformation Practitioner & a Certified Technology Innovation Practitioner. He is also a member of the Forbes Technology Council. He was publicly recognized for global transformation leadership when he was featured on billboards across Germany during a major enterprise program at Bayer. Ganesh is known for partnering with boards, CEOs, CFOs, & private equity operating teams. He aligns technology strategy with growth objectives, cost discipline, compliance needs, & long-term enterprise value. Based in Atlanta, he is regarded as a CIO leader who turns complexity into clarity and who consistently converts technology investment into measurable business outcomes.

Dr. Lisa Piper, PhD Founder at CODE Health Dr. Lisa Piper is a pioneer in the field of holistic health and wellness, recognized for her innovative approach to integrating science, spirituality, and natural medicine. As a Board-Certified Doctor of Natural Medicine (DNM), Dr. Piper is devoted to empowering individuals on their journey to optimal health and vitality. Dr. Piper holds a bachelor’s degree in business management and a master’s degree in health psychology, with a focus on mindful stress reduction strategies. She holds a Doctorate in Natural Medicine and specializes in mind body spirit medicine and consciousness. Her credentials include certifications in life coaching, hypnosis, quantum health coaching, multiple energy medicine practices, and kundalini yoga instruction. As a member of The National Society of Leadership and Success and a Board-Certified Doctor of Natural Medicine and Humanitarian Services, Dr. Piper is a thought leader in the health and wellness industry, constantly advancing the conversation around holistic healing. Dr. Piper is the visionary co-founder of CODE Health, a cutting-edge therapeutic product company that focuses on developing bioenergetic solutions to optimize physical, emotional, and energetic well-being. She spearheads research, product development, and education, providing practitioners and clients with personalized wellness solutions. Her intuitive understanding of consciousness and the energy behind healing drives her mission to transform healthcare with safe and effective complementary alternatives. With a direct yet compassionate approach, Dr. Piper inspires individuals to take control of their health and live their best lives. As a keynote speaker, educator, and advocate for integrative health, she is dedicated to creating a meaningful and lasting impact on her clients and the broader community. Her vision for the future of wellness, combined with her innovative leadership at CODE Health, continues to redefine the possibilities of holistic health, one breakthrough at a time. @drlisapiper